AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by AC Immune SA covers the month of November 2020. The report discloses the results of an Extraordinary General Meeting held on November 20, 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters.
Material Changes
The primary material change reported is the approval of a new Board of Director member. No financial changes or operational shifts are detailed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, risks, contingencies, or unusual items. The content is limited to the voting results of the shareholder meeting.
Key Facts for Investors
- Shareholders approved the election of Carl June as a new member of the Board of Directors.
- The term for the new director extends until the end of the next ordinary General Meeting.
- The filing includes a press release dated November 20, 2020, as Exhibit 99.1.
- No financial performance data is included in this specific filing.